UroGen Pharma Announces March 2021 Conference Schedule
A replay of each webcast will be available on the Companys website for approximately 30 days.
- A replay of each webcast will be available on the Companys website for approximately 30 days.
- UroGen is a biopharmaceutical company dedicated to building novel solutions that treat specialty cancers and urologic diseases because patients deserve better options.
- UroGen has developed RTGel reverse-thermal hydrogel, a proprietary sustained release, hydrogel-based platform technology that has the potential to improve therapeutic profiles of existing drugs.
- UroGen is headquartered in Princeton, NJ with operations in Israel.